# GeneScience Pharmaceuticals Co.

GeneScience Pharmaceuticals Co. is an other based in Changchun, China.

## Overview

- **Organization type:** other
- **Headquarters:** Changchun, China
- **Region:** Asia
- **Address:** Changchun, China
- **Founded:** 1997
- **Assets under management:** Undisclosed
- **Website:** gensci-china.com

## Regulatory record

- **Reports private funds:** No

## About

GeneScience Pharmaceuticals Co., also known as Changchun GeneScience Pharmaceuticals Co., Ltd., develops drugs. It operates a technology platform with global reach and maintains a research and development pipeline. Progress has occurred in endocrine metabolism, women's health, and oncology.

## Sectors

- Healthcare Services
- Biotech
- Pharmaceuticals

## Offices

- Shanghai
- Mountain View
- Basingstoke
- Shenzhen
- San Francisco
- Basel
- London
- Taipei

## People

- unspecified — 总经理, 首席科学家

## Questions

### Who runs investment decisions at GeneScience Pharmaceuticals?

The firm’s chief scientist — who also serves as general manager and holds a PhD from the University of California — leads both R&D and corporate strategy. The board is ultimately controlled by state-owned Changchun High-Tech (SZ000661).

### How does GeneScience source proprietary drug development?

GeneScience uses AI-driven molecular design and four core technology platforms: AI, precision targeting, multifunctional molecules, and long-acting formulations. It also in-licenses foreign assets and out-licenses its own molecules globally, as demonstrated by the 2025 Yarrow deal.

### What investment stages does GeneScience typically target?

GeneScience focuses on preclinical through Phase III clinical development. It has 40-plus assets in clinical phases and over 35 Class 1 new drugs. It also commercializes approved drugs across 40-plus countries.

### Which sectors does GeneScience explicitly avoid?

The firm does not publicly disclose excluded sectors. Its stated focus is endocrinology, oncology, women’s health, immunology, and rare diseases.

### How is GeneScience related to Changchun High-Tech?

GeneScience is a controlled subsidiary of Changchun High-Tech (stock code SZ000661), a state-owned enterprise listed on the Shenzhen Stock Exchange. Changchun High-Tech consolidates GeneScience’s financial results.

## Related profiles

- [W&W-AFCO Steel LLC](https://altss.com/profile/wandw-afco-steel-llc)
- [Cathay Financial Holding Co.](https://altss.com/profile/cathay-financial-holding-co)

---

Last updated: 2026-07-11T16:24:19.000Z

Canonical page: https://altss.com/profile/genescience-pharmaceuticals-co

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology